Fax: (713) 792-5529
The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis
Article first published online: 24 OCT 2006
Copyright © 2006 American Cancer Society
Volume 107, Issue 11, pages 2730–2740, 1 December 2006
How to Cite
Rosen, D. G., Mercado-Uribe, I., Yang, G., Bast, R. C., Amin, H. M., Lai, R. and Liu, J. (2006), The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer, 107: 2730–2740. doi: 10.1002/cncr.22293
- Issue published online: 17 NOV 2006
- Article first published online: 24 OCT 2006
- Manuscript Accepted: 5 SEP 2006
- Manuscript Revised: 29 AUG 2006
- Manuscript Received: 12 MAY 2006
- American Cancer Society Research Scholar. Grant Number: RSG-04-028-1-CCE
- signal transducer and activator of transcription 3;
- tissue microarray;
- prognostic marker;
- ovarian cancer
Signal transducer and activator of transcription 3 (Stat3), which is a latent transcription factor that participates in the transcriptional activation of apoptosis and cell cycle progression, has been implicated as an oncogene in several neoplastic diseases. However, the specific role of Stat3 in ovarian carcinogenesis remains poorly understood. The objectives of the current study were to examine the effect of Stat3 activation on the phenotypic transformation of an immortalized, nontumorigenic ovarian epithelial cell line and to evaluate the expression of tyrosine-activated Stat3 (pStat3) in tissue microarrays from 303 ovarian carcinomas to determine its prognostic relevance and to correlate its expression with several upstream oncogenes of Stat3 and with the oncogenes involved in apoptosis and proliferation.
Overexpression of pStat3 was weakly tumorigenic and produced measurable tumors in mice in 1 of 3 clones. Using tissue microarrays from a large group of patients with primary ovarian carcinoma, the expression of pStat3 was correlated with the expression of growth factor receptors (HER-2/neu and epidermal growth factor receptor [EGFR]), interleukin 6, and the proliferation and apoptosis markers Ki-67, Bcl-2, and Bcl-xL and with clinicopathologic variables and patient survival.
High pStat3 expression in the tumor tissue microarray was associated with high levels of HER-2/neu, EGFR, and Ki-67. No correlation was observed between overall pStat3 levels and any other clinicopathologic variables tested. High nuclear expression of pStat3 (>10% of positive-stained cells) was linked with poor overall survival.
The activation and translocation of pStat3 to the nucleus are frequent events in ovarian carcinoma that are associated with a poor prognosis. Further studies are needed to elucidate the mechanism of activation of Stat3, its effects on downstream targets, and its role in the neoplastic transformation of epithelial ovarian cells. Cancer 2006. © 2006 American Cancer Society.